{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:13:20Z","timestamp":1790187200900,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81073111"],"award-info":[{"award-number":["81073111"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)","award":["Nzyzyxjp-1006"],"award-info":[{"award-number":["Nzyzyxjp-1006"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.lfs.2014.12.028","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T17:19:37Z","timestamp":1422033577000},"page":"78-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Loganin attenuates diabetic nephropathy in C57BL\/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products"],"prefix":"10.1016","volume":"123","author":[{"given":"Kai","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaohong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell Kim Kit","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2014.12.028_bb0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.2040-1124.2011.00131.x","article-title":"Pathogenesis of diabetic nephropathy","volume":"2","author":"Cao","year":"2011","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.lfs.2014.12.028_bb0010","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/sj.bjp.0706684","article-title":"Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats","volume":"147","author":"Chang","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2014.12.028_bb0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jep.2008.02.032","article-title":"Fructus Corni suppresses hepatic gluconeogenesis related gene transcription, enhances glucose responsiveness of pancreatic beta-cells, and prevents toxin induced beta-cell death","volume":"117","author":"Chen","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2014.12.028_bb0020","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.2174\/09298673113209990025","article-title":"Advanced glycation end products and diabetic retinopathy","volume":"20","author":"Chen","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.lfs.2014.12.028_bb0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.2042-7158.2012.01585.x","article-title":"Protective effects of captopril in diabetic rats exposed to ischemia\/reperfusion renal injury","volume":"65","author":"Fouad","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.lfs.2014.12.028_bb0030","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2174\/138161208784139710","article-title":"Role of AGEs in diabetic nephropathy","volume":"14","author":"Fukami","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2014.12.028_bb0035","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/15733998113099990066","article-title":"Advanced glycation end products: a link between periodontitis and diabetes mellitus?","volume":"9","author":"Gurav","year":"2013","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.lfs.2014.12.028_bb0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1574884711308040004","article-title":"The renin\u2013angiotensin system and advanced glycation end-products in diabetic retinopathy: impacts and synergies","volume":"8","author":"Miller","year":"2013","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2014.12.028_bb0045","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00726-011-1071-3","article-title":"Advanced glycation end products and diabetic retinopathy","volume":"44","author":"Milne","year":"2013","journal-title":"Amino Acids"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2014.12.028_bb0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/10715762.2013.806798","article-title":"Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology","volume":"47","author":"Nedic","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.lfs.2014.12.028_bb0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tox.2011.08.004","article-title":"Hepato-protective effects of loganin, iridoid glycoside from Corni Fructus, against hyperglycemia-activated signaling pathway in liver of type 2 diabetic db\/db mice","volume":"290","author":"Park","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.lfs.2014.12.028_bb0060","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/0026-0495(93)90190-Y","article-title":"Regional fat distribution and metabolism in a new mouse model (C57BL\/6J) of non-insulin-dependent diabetes mellitus","volume":"42","author":"Rebuffe-Scrive","year":"1993","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.lfs.2014.12.028_bb0065","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cellsig.2012.11.022","article-title":"The receptor for advanced glycation end-products: a complex signaling scenario for a promiscuous receptor","volume":"25","author":"Rojas","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2014.12.028_bb0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11906-003-0075-0","article-title":"Angiotensin II and the glomerulus: focus on diabetic kidney disease","volume":"5","author":"Scholey","year":"2003","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.lfs.2014.12.028_bb0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/138945009787122905","article-title":"Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy \u2014 are these receptors valid therapeutic targets","volume":"10","author":"Sourris","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.lfs.2014.12.028_bb0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbrc.2013.02.120","article-title":"Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy","volume":"433","author":"Sun","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2014.12.028_bb0085","doi-asserted-by":"crossref","first-page":"F763","DOI":"10.1152\/ajprenal.00591.2009","article-title":"Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy","volume":"298","author":"Tan","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.lfs.2014.12.028_bb0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1196\/annals.1333.051","article-title":"Advanced glycation in health and disease: role of the modern environment","volume":"1043","author":"Vlassara","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.lfs.2014.12.028_bb0095","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.cellsig.2013.06.013","article-title":"Cellular signalling of the receptor for advanced glycation end products (RAGE)","volume":"25","author":"Xie","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.lfs.2014.12.028_bb0100","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1248\/bpb.27.1014","article-title":"Effects of iridoid total glycoside from cornus officinalis on prevention of glomerular overexpression of transforming growth factor beta 1 and matrixes in an experimental diabetes model","volume":"27","author":"Xu","year":"2004","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2014.12.028_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejphar.2010.08.044","article-title":"Evaluation of loganin, iridoid glycoside from Corni Fructus, on hepatic and renal glucolipotoxicity and inflammation in type 2 diabetic db\/db mice","volume":"648","author":"Yamabe","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2014.12.028_bb0110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4161\/oxim.3.2.11148","article-title":"Advanced glycation end products, oxidative stress and diabetic nephropathy","volume":"3","author":"Yamagishi","year":"2010","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2014.12.028_bb0115","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.mehy.2008.07.034","article-title":"Possible link of food-derived advanced glycation end products (AGEs) to the development of diabetes","volume":"71","author":"Yamagishi","year":"2008","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.lfs.2014.12.028_bb0120","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.2174\/138161207781757051","article-title":"Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders","volume":"13","author":"Yamagishi","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2014.12.028_bb0125","first-page":"2013","article-title":"Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the chinese population","volume":"264579","author":"Yang","year":"2013","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.lfs.2014.12.028_bb0130","first-page":"223","article-title":"Bioactive constituents of Corni Fructus: The therapeutic use of morroniside, loganin, and 7-O-galloyl-D-sedoheptulose as renoprotective agents in type 2 diabetes","volume":"4","author":"Yokozawa","year":"2010","journal-title":"Drug Discov. Ther."},{"key":"10.1016\/j.lfs.2014.12.028_bb0135","doi-asserted-by":"crossref","first-page":"463815","DOI":"10.1155\/2014\/463815","article-title":"The attenuation of Moutan Cortex on oxidative stress for renal injury in AGEs-induced mesangial cell dysfunction and streptozotocin-induced diabetic nephropathy rats","volume":"2014","author":"Zhang","year":"2014","journal-title":"Oxidative Med. Cell. Longev."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515000399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515000399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T23:01:11Z","timestamp":1537916471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320515000399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":27,"alternative-id":["S0024320515000399"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2014.12.028","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loganin attenuates diabetic nephropathy in C57BL\/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2014.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}